Jiaji Yu

874 total citations
13 papers, 374 citations indexed

About

Jiaji Yu is a scholar working on Immunology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jiaji Yu has authored 13 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Oncology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jiaji Yu's work include CAR-T cell therapy research (6 papers), Immune Cell Function and Interaction (5 papers) and T-cell and B-cell Immunology (3 papers). Jiaji Yu is often cited by papers focused on CAR-T cell therapy research (6 papers), Immune Cell Function and Interaction (5 papers) and T-cell and B-cell Immunology (3 papers). Jiaji Yu collaborates with scholars based in United States, China and Australia. Jiaji Yu's co-authors include Lili Yang, Yang Zhou, Yu-Chen Wang, Angela To, Yan-Ruide Li, Nicole Clarke, Xi Wang, Zhe Li, Samuel Zeng and Feiyang Ma and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Jiaji Yu

11 papers receiving 367 citations

Peers

Jiaji Yu
Jiaji Yu
Citations per year, relative to Jiaji Yu Jiaji Yu (= 1×) peers Jingyuan Song

Countries citing papers authored by Jiaji Yu

Since Specialization
Citations

This map shows the geographic impact of Jiaji Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiaji Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiaji Yu more than expected).

Fields of papers citing papers by Jiaji Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiaji Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiaji Yu. The network helps show where Jiaji Yu may publish in the future.

Co-authorship network of co-authors of Jiaji Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiaji Yu. A scholar is included among the top collaborators of Jiaji Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiaji Yu. Jiaji Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Li, Yan-Ruide, Kuangyi Zhou, Yichen Zhu, et al.. (2025). Generating allogeneic CAR-NKT cells for off-the-shelf cancer immunotherapy with genetically engineered HSP cells and feeder-free differentiation culture. Nature Protocols. 20(5). 1352–1388. 12 indexed citations
2.
Zhu, Enbo, Jiaji Yu, Yan-Ruide Li, et al.. (2024). Biomimetic cell stimulation with a graphene oxide antigen-presenting platform for developing T cell-based therapies. Nature Nanotechnology. 19(12). 1914–1922. 12 indexed citations
3.
Yu, Jiaji, Manman Liu, Ronghua Zhao, et al.. (2024). Anti-PD-L1 nanobody guided in situ self-assembly and release of IOX1 and FDU for enhanced cancer chemo-immunotherapy. Nano Today. 56. 102240–102240. 5 indexed citations
5.
Zhu, Enbo, Yang Liu, Jin Huang, et al.. (2023). Bubble-Mediated Large-Scale Hierarchical Assembly of Ultrathin Pt Nanowire Network Monolayer at Gas/Liquid Interfaces. ACS Nano. 17(14). 14152–14160. 7 indexed citations
6.
Li, Yan-Ruide, Samuel Zeng, Zachary Spencer Dunn, et al.. (2022). Off-the-shelf third-party HSC-engineered iNKT cells for ameliorating GvHD while preserving GvL effect in the treatment of blood cancers. iScience. 25(9). 104859–104859. 26 indexed citations
7.
Li, Yan-Ruide, Zachary Spencer Dunn, Gustavo Garcia, et al.. (2022). Development of off-the-shelf hematopoietic stem cell-engineered invariant natural killer T cells for COVID-19 therapeutic intervention. Stem Cell Research & Therapy. 13(1). 112–112. 23 indexed citations
8.
Wang, Yu-Chen, Xi Wang, Jiaji Yu, et al.. (2021). Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy. Nature Communications. 12(1). 3530–3530. 120 indexed citations
9.
Zhou, Yongchun, et al.. (2021). A neutral polysaccharide from Ophiocordyceps lanpingensis restrains cisplatin‐induced nephrotoxicity. Food Science & Nutrition. 9(7). 3602–3616. 10 indexed citations
10.
Zhou, Yongchun, Jiaji Yu, Yong Tan, et al.. (2020). Ophiocordyceps lanpingensis polysaccharides attenuate pulmonary fibrosis in mice. Biomedicine & Pharmacotherapy. 126. 110058–110058. 23 indexed citations
11.
Biase, Stefano Di, Xi Wang, Jiaji Yu, et al.. (2019). Creatine uptake regulates CD8 T cell antitumor immunity. The Journal of Experimental Medicine. 216(12). 2869–2882. 83 indexed citations
12.
Bethune, Michael T., Xiaohua Li, Jiaji Yu, et al.. (2018). Isolation and characterization of NY-ESO-1–specific T cell receptors restricted on various MHC molecules. Proceedings of the National Academy of Sciences. 115(45). E10702–E10711. 53 indexed citations
13.
Yu, Jiaji, Jiabin Yu, Cheng Wang, et al.. (2015). The Research and Design on Autonomous Navigation Water Quality Monitoring Ship.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026